Search

Late Holocene diatoms were identified from four sediment cores from the Gonggeomji Wetland in Korea. In total, 52 diatom species belonging to three classes, 21 families, and 29 genera were investigated. Of these, 14 species were new records for Korea: Caloneis wardii, Cocconeis klamathensis, Encyonema vulgare, Eunotia myrmica, Fallacia californica, Gomphonema asiaticum, Gomphonema insigniturris, Gomphonema neoapiculatum, Gomphonema tumens, Pinnularia fusana, Pinnularia parvulissima, Punctastriata lancettula, Sellaphora capitata, and Staurosira dimorpha. Eleven taxa could not be identified to the species level. All identified diatoms are illustrated by high-quality scanning electron microphotographs, reference taxonomic data, dimensions of the observed cells, and information on ecology and distribution are included. [ABSTRACT FROM AUTHOR]

Thalassiosira species are an important component of phytoplankton populations, and most species are considered cosmopolitan. Many authors have investigated the diversity of Thalassiosira species in order to understand their ecological roles in local areas. Our regional taxonomic study revealed the presence of 44 Thalassiosira species at 124 sites in Korean coastal waters. Of these, 14 species are newly reported in Korean waters and are described in detail with external and internal valve illustrations. Some morphologically confused taxa, such as the Thalassiosira s.s. group, T. curviseriata/ T. tealata, T. simonsenii/ Planktoniella blanda and T. proschkinae/ T. spinulata, are clearly distinguished using additional morphological criteria. In addition, the full biogeographical distribution of Thalassiosira is described and compared with the Korean species. Korean waters seem to be the 'Maginot Line' for the cold- and warm-water Thalassiosira species. Knowledge of Thalassiosira species diversity will increase with more intensive work in relatively little-studied regions, such as the Indo-Pacific and tropical Atlantic Oceans. [ABSTRACT FROM AUTHOR]

The in vivo fate of drugs conjugated to macromolecules inevitably depends on that of macromolecules. However, the in vivo fate of macromolecules also may be altered by conjugation to drugs. For the efficient design of carboxymethyldextran (CMD) conjugates of a new analgesic drug, DA5018, we investigated whether the chemical modifications alter the pharmacokinetics and tissue distribution of CMD itself. [[sup 14] C]CMD, oxidized [[sup 14] C]CMD ([[sup 14] C]OCMD), [[sup 14] C]OCMD conjugates of DA5018 ([[sup 14] C]OCMD-DA5018) and [[sup 14] C]OCMD conjugates of ethanolamine ([[sup 14] C]OCMD-EA) were prepared and their molecular sizes were compared by size exclusion HPLC. The pharmacokinetics, biliary excretion, and tissue distribution of total radioactivity were compared after intravenous administration of each CMD derivative, 2.0 MBq/kg, to rats. The effective molecular sizes of CMD derivatives decreased in the order of [[sup 14] C]CMD, [[sup 14] C]OCMD-DA5018, [[sup 14] C]OCMD, and [[sup 14] C]OCMD-EA. After administration of each derivative, the mean AUC values of total radioactivity decreased with the decrease in the effective molecular size. The values of CL, Vss, and the amount of total radioactivity excreted in 24-hr urine increased considerably with the decrease in the effective molecular size. The tissue-to-plasma ratios of total radioactivity remaining in heart, liver, lung, kidney, and spleen at 24 hr also increased in the opposite order of the effective molecular size. Taken together, all these results demonstrate that the chemical modifications and physicochemical properties of attached chemicals can alter the pharmacokinetics and tissue distribution of CMD. One possible reason might be the difference in the effective molecular size of various CMD derivatives. Our study demonstrates that it may be necessary to consider the effect of chemical modification on the in vivo fate of macromolecules in designing macromolecular drug conjugates. [ABSTRACT FROM AUTHOR]